Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for GoodRx Holdings, Inc. (GDRX : NSDQ)
 
 • Company Description   
GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

Number of Employees: 777

 
 • Price / Volume Information   
Yesterday's Closing Price: $7.50 Daily Weekly Monthly
20 Day Moving Average: 3,435,484 shares
Shares Outstanding: 396.46 (millions)
Market Capitalization: $2,973.43 (millions)
Beta: 0.29
52 Week High: $48.05
52 Week Low: $7.33
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -52.01% -49.17%
12 Week -55.20% -51.05%
Year To Date -77.05% -72.25%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2701 OLYMPIC BOULEVARD
-
SANTA MONICA,CA 90404
USA
ph: 855-268-2822
fax: -
wnotaro@goodrx.com http://www.goodrx.com
 
 • General Corporate Information   
Officers
Douglas Hirsch - Co-Chief Executive Officer
Trevor Bezdek - Co-Chief Executive Officer
Karsten Voermann - Chief Financial Officer
Christopher Adams - Director
Julie Bradley - Director

Peer Information
GoodRx Holdings, Inc. (CHCR)
GoodRx Holdings, Inc. (ESRX)
GoodRx Holdings, Inc. (MYDP)
GoodRx Holdings, Inc. (GBCS)
GoodRx Holdings, Inc. (LAXAF)
GoodRx Holdings, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 38246G108
SIC: 7374
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 396.46
Most Recent Split Date: (:1)
Beta: 0.29
Market Capitalization: $2,973.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.10 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 16.17% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 72.58
Trailing 12 Months: 250.00
PEG Ratio: 4.49
Price Ratios
Price/Book: 3.78
Price/Cash Flow: 64.20
Price / Sales: 3.77
EPS Growth
vs. Year Ago Period: 400.00%
vs. Previous Quarter: 200.00%
Sales Growth
vs. Year Ago Period: 26.74%
vs. Previous Quarter: -4.65%
ROE
03/31/22 - 2.86
12/31/21 - 0.06
09/30/21 - -31.61
ROA
03/31/22 - 1.48
12/31/21 - 0.03
09/30/21 - -16.01
Current Ratio
03/31/22 - 16.76
12/31/21 - 13.42
09/30/21 - 14.47
Quick Ratio
03/31/22 - 16.76
12/31/21 - 13.42
09/30/21 - 14.47
Operating Margin
03/31/22 - 2.99
12/31/21 - 0.06
09/30/21 - -36.08
Net Margin
03/31/22 - -1.86
12/31/21 - -3.39
09/30/21 - -41.36
Pre-Tax Margin
03/31/22 - 1.86
12/31/21 - -1.37
09/30/21 - -46.91
Book Value
03/31/22 - 1.98
12/31/21 - 2.08
09/30/21 - 2.12
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.83
12/31/21 - 0.79
09/30/21 - 0.78
Debt-to-Capital
03/31/22 - 45.43
12/31/21 - 44.09
09/30/21 - 43.70
 

Powered by Zacks Investment Research ©